Compare ADI & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADI | TMO |
|---|---|---|
| Founded | 1965 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Industrial Machinery/Components |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 203.3B | 164.3B |
| IPO Year | 1994 | 1996 |
| Metric | ADI | TMO |
|---|---|---|
| Price | $412.43 | $493.80 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 22 | 18 |
| Target Price | $385.45 | ★ $636.00 |
| AVG Volume (30 Days) | ★ 3.7M | 2.3M |
| Earning Date | 05-20-2026 | 04-23-2026 |
| Dividend Yield | ★ 1.13% | 0.40% |
| EPS Growth | ★ 39.02 | 7.32 |
| EPS | 4.09 | ★ 4.43 |
| Revenue | $6,200,942,000.00 | ★ $20,918,000,000.00 |
| Revenue This Year | $28.41 | $6.55 |
| Revenue Next Year | $10.25 | $5.11 |
| P/E Ratio | ★ $102.55 | $109.65 |
| Revenue Growth | ★ 21.41 | 14.47 |
| 52 Week Low | $212.22 | $385.46 |
| 52 Week High | $435.72 | $643.99 |
| Indicator | ADI | TMO |
|---|---|---|
| Relative Strength Index (RSI) | 55.88 | 62.92 |
| Support Level | $230.02 | $493.64 |
| Resistance Level | $435.72 | $502.20 |
| Average True Range (ATR) | 14.77 | 13.68 |
| MACD | -2.50 | 5.75 |
| Stochastic Oscillator | 58.57 | 92.44 |
Analog Devices is a leading analog, mixed-signal, and digital-signal processing chipmaker. The firm has a significant market share lead in converter chips, which are used to translate analog signals to digital and vice versa. The company serves tens of thousands of customers; more than half of its chip sales are to industrial and automotive end markets. ADI's chips are also incorporated into wireless infrastructure equipment.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).